These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 8972011

  • 21. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A cross sectional study of antiphospholipid-protein antibodies in patients with venous thromboembolism.
    Pasquier E, Amiral J, de Saint Martin L, Mottier D.
    Thromb Haemost; 2001 Aug; 86(2):538-42. PubMed ID: 11522000
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.
    Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963
    [Abstract] [Full Text] [Related]

  • 26. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun 15; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 27. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T, Julkunen H, Vaarala O, Leirisalo-Repo M, Stephansson E, Vahtera E, Palosuo T, Myllylä G.
    Blood Coagul Fibrinolysis; 1992 Aug 15; 3(4):407-14. PubMed ID: 1420816
    [Abstract] [Full Text] [Related]

  • 28. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, Todoli J, Simó M, Corella D, Ricart JM.
    Clin Hemorheol Microcirc; 2008 Aug 15; 40(2):79-87. PubMed ID: 19029633
    [Abstract] [Full Text] [Related]

  • 29. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct 15; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 30. Thrombosis risk in systemic lupus erythematosus: the role of thrombophilic risk factors.
    Sallai KK, Nagy E, Bodó I, Mohl A, Gergely P.
    Scand J Rheumatol; 2007 Oct 15; 36(3):198-205. PubMed ID: 17657674
    [Abstract] [Full Text] [Related]

  • 31. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
    Arvieux J, Darnige L, Hachulla E, Roussel B, Bensa JC, Colomb MG.
    Thromb Haemost; 1996 May 15; 75(5):725-30. PubMed ID: 8725713
    [Abstract] [Full Text] [Related]

  • 32. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B, Tavori S, Lerner M, Tatarsky I, Lorber M.
    Isr J Med Sci; 1992 Jan 15; 28(1):9-15. PubMed ID: 1733904
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS, Kim KE, Kim JM, Han JY, Chung WT, Kim KH.
    Korean J Lab Med; 2010 Feb 15; 30(1):38-44. PubMed ID: 20197721
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C, Meyer O, Dosquet C, Montes de Oca M, Babron MC, Danon F, Kaplan C, Clémenceau S, Castellano F, Levy M.
    Pediatrics; 1993 Dec 15; 92(6):849-53. PubMed ID: 8233748
    [Abstract] [Full Text] [Related]

  • 39. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A.
    Arthritis Rheum; 2005 Jun 15; 53(3):452-9. PubMed ID: 15934123
    [Abstract] [Full Text] [Related]

  • 40. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
    Nojima J.
    Rinsho Byori; 2003 Mar 15; 51(3):239-47. PubMed ID: 12707997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.